We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
+7.52%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$104B
AUM Growth
+$6.58B
Cap. Flow
-$453M
Cap. Flow %
-0.43%
Top 10 Hldgs %
10.66%
Holding
2,865
New
128
Increased
1,119
Reduced
1,402
Closed
129

Sector Composition

Rank Sector Weight
1 Technology 17.57%
2 Industrials 13.85%
3 Financials 12.11%
4 Consumer Discretionary 11.36%
5 Healthcare 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XTNT icon
2676
Xtant Medical Holdings
XTNT
$62.3M
$22K ﹤0.01%
13,526
+1,013
+8% +$1.8K
ABEO icon
2677
Abeona Therapeutics
ABEO
$413M
$21K ﹤0.01%
543
-20
-4% -$816
PTN
2678
Palatin Technologies
PTN
$13.8M
$21K ﹤0.01%
27
-1
-4% -$728
XTIA icon
2679
XTI Aerospace
XTIA
$58.9M
0
SVRA icon
2680
Savara
SVRA
$1.19B
$19K ﹤0.01%
11,102
-3,024
-21% -$5.44K
VGZ icon
2681
Vista Gold
VGZ
$308M
$19K ﹤0.01%
15,590
-366
-2% -$422
CATX icon
2682
Perspective Therapeutics
CATX
$342M
$18K ﹤0.01%
2,229
-65
-3% -$569
COCP icon
2683
Cocrystal Pharma
COCP
$14.6M
$18K ﹤0.01%
+1,178
New +$17.9K
FTK icon
2684
Flotek Industries
FTK
$1.28B
$18K ﹤0.01%
1,719
-62
-3% -$668
AVGR
2685
DELISTED
Avinger, Inc. Common Stock
AVGR
$18K ﹤0.01%
49
-1
-2% -$347
IMNN icon
2686
Imunon
IMNN
$6.77M
$17K ﹤0.01%
69
+7
+11% +$1.66K
INUV icon
2687
Inuvo
INUV
$17M
$16K ﹤0.01%
1,700
-52
-3% -$417
BIOL
2688
DELISTED
Biolase, Inc.
BIOL
$16K ﹤0.01%
9
ZSAN
2689
DELISTED
Zosano Pharma Corporation
ZSAN
$16K ﹤0.01%
476
+7
+1% +$226
UAMY icon
2690
United States Antimony
UAMY
$1.02B
$14K ﹤0.01%
14,533
-1,161
-7% -$1.08K
AGRX
2691
DELISTED
Agile Therapeutics
AGRX
$14K ﹤0.01%
5
DOMH icon
2692
Dominari Holdings
DOMH
$55.4M
$13K ﹤0.01%
780
+45
+6% +$771
AGPU
2693
Axe Compute Inc
AGPU
$96.6M
$13K ﹤0.01%
+34
New +$11.8K
RNTX
2694
Rein Therapeutics
RNTX
$69.9M
$13K ﹤0.01%
520
-23
-4% -$574
REED
2695
DELISTED
Reeds, Inc. Common Stock
REED
$13K ﹤0.01%
260
+30
+13% +$1.54K
OGEN icon
2696
Oragenics
OGEN
$2.48M
$12K ﹤0.01%
9
RMTI icon
2697
Rockwell Medical
RMTI
$28.2M
$12K ﹤0.01%
117
-3
-3% -$310
TOVX icon
2698
Theriva Biologics
TOVX
$10.1M
$12K ﹤0.01%
82
-1
-1% -$143
AUMN
2699
DELISTED
Golden Minerals Company
AUMN
$12K ﹤0.01%
789
-24
-3% -$428
PTE
2700
DELISTED
PolarityTE, Inc. Common Stock
PTE
$12K ﹤0.01%
+462
New +$12.1K

Similar funds

Victory Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Victory Capital Management held 2,865 positions worth $104B, up 6.7% from $97.6B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Victory Capital Management's Q2 2021 filing shows 128 new, 1,119 increased, 1,402 reduced and 129 closed positions. Its largest new stake was iShares Core S&P Mid-Cap ETF: 6,251,880 shares worth $336M. The largest sale was Darden Restaurants, an estimated $302M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.

  • Victory Capital Management's largest Q2 2021 buy was iShares Core S&P Mid-Cap ETF: 6,251,880 shares worth $336M.
  • Victory Capital Management added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $1.28B increase.
  • Victory Capital Management's biggest Q2 2021 reduction was Darden Restaurants, cutting an estimated $302M.
  • Victory Capital Management fully exited TCF Financial Corporation Common Stock in Q2 2021, selling an estimated $245M.
  • Victory Capital Management's ten largest holdings make up 11% of its $104B portfolio in Q2 2021.
  • Victory Capital Management opened 128 new positions and closed 129 in Q2 2021.
  • Victory Capital Management's portfolio value rose 6.7% quarter-over-quarter to $104B.

Based on Victory Capital Management's 13F filing for Q2 2021, filed 3 Aug 2021.